Indication · Laboratory Medicine & Pathology
Anemia, clotting and blood disorders
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
564
Cleared or approved since 2000
PMA and De Novo
17
Higher-risk or first-of-kind devices
Breakthrough devices
1
Authorized through June 30, 2026
Recruiting device trials
31
280 device trials in all
Breakthrough-designated devices
- ConcizuTrace ELISARandox Laboratories, Ltd. · 2025
Devices
3 devices via PMA. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- Prosorba Column
Fresenius Hemocare, Inc. · PMA · Separator, Automated, Blood Cell And Plasma, Therapeutic · newest 2004 · 3 decisions
2 more devices with a free account
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
National Heart, Lung, and Blood Institute (NHLBI)NIH
NCT01174108 · 120 participants (planned) · Start Dec 10, 2010 · Primary completion Dec 30, 2027
Device: Miltenyi CD34 Reagent System · For: Severe Aplastic Anemia; MDS (Myelodysplastic Syndrome)
Sites: Baltimore, Maryland; Bethesda, Maryland
279 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- System, Multipurpose For In Vitro Coagulation Studies (JPA)53
- Plasma, Coagulation Control (GGN)42
- Test, Qualitative And Quantitative Factor Deficiency (GGP)37
- Test, Time, Prothrombin (GJS)37
- System, Test, Anticardiolipin Immunological (MID)33
- Radioassay, Vitamin B12 (CDD)22
- System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi) (MSV)22
- Device, Automated Cell-Locating (JOY)19
- System, Automated Platelet Aggregation (JOZ)17
- Transferrin, Antigen, Antiserum, Control (DDG)16
- Ferritin, Antigen, Antiserum, Control (DBF)15
- Acid, Folic, Radioimmunoassay (CGN)14
- Abnormal Hemoglobin Quantitation (GKA)14
- System, Hemoglobin, Automated (GKR)14
- Separator, Automated, Blood Cell And Plasma, Therapeutic (LKN)12
- Control, Plasma, Abnormal (GGC)11
- Antithrombin Iii Quantitation (JBQ)10
- Platelet Factor 4 Radioimmunoassay (LCO)10
- Activated Whole Blood Clotting Time (JBP)9
- Activated Partial Thromboplastin (GFO)8
- Control, Hemoglobin (GGM)7
- Instrument, Coagulation, Automated (GKP)7
- Photometric Method, Iron (Non-Heme) (JIY)7
- Ferrozine (Colorimetric) Iron Binding Capacity (JMO)7
- Irradiator, Blood To Prevent Graft Versus Host Disease (MOT)7
- Test, Time, Partial Thromboplastin (GGW)6
- Reagent, Russel Viper Venom (GIR)6
- Whole Blood Hemoglobin Determination (KHG)6
- Test, Factor V Leiden Mutations, Genomic Dna Pcr (NPQ)6
- Bcr/Abl1 Monitoring Test (OYX)6
Research
- Device studies on anemia across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.